Shuttle Pharmaceuticals Holdings (SHPH) Retained Earnings (2021 - 2026)

Shuttle Pharmaceuticals Holdings (SHPH) recorded quarterly Retained Earnings of -$48.5 million in Q1 2026, down 4.65% quarter-over-quarter from -$46.3 million in Q4 2025, and down 28.76% on a YoY basis from -$68.0 million in Q1 2025.

Shuttle Pharmaceuticals Holdings (SHPH) Retained Earnings (2021 - 2026) Analysis & Trends

Shuttle Pharmaceuticals Holdings' Retained Earnings history runs 6 years deep, the most recent figure standing at -$48.5 million for Q1 2026.

  • In Q1 2026, Retained Earnings fell 28.76% year-over-year to -$48.5 million; the TTM figure through Mar 2026 stood at -$48.5 million (down 28.76% YoY), while the FY2025 annual figure was -$46.3 million, down 33.9% from the prior year.
  • Retained Earnings was -$48.5 million for Q1 2026 at Shuttle Pharmaceuticals Holdings, down from -$46.3 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$8.1 million in Q3 2022 to a low of -$48.5 million in Q1 2026.
  • Historically, Retained Earnings has averaged -$29.3 million across 5 years, with a median of -$29.2 million in 2024.
  • The sharpest annual moves came in 2023 and 2026: Retained Earnings slumped 192.15% in 2023, then dropped 28.76% in 2026.
  • A 5-year view of Retained Earnings shows it stood at -$18.8 million in 2022, then tumbled by 34.99% to -$25.4 million in 2023, then tumbled by 35.96% to -$34.6 million in 2024, then sank by 33.9% to -$46.3 million in 2025, then declined by 4.65% to -$48.5 million in 2026.
  • The last three Retained Earnings figures came in at -$48.5 million (Q1 2026), -$46.3 million (Q4 2025), and -$43.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -2.51 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -772.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -10.20 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 683,383.23
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 589.60 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -2.13 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -2.91 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -4.41 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -1.87 Mn
10 Shuttle Pharmaceuticals Holdings 2.17 Mn 1.11 Mn - -48.45 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -48.45 Mn
Dec 31, 2025 -46.30 Mn
Sep 30, 2025 -43.68 Mn
Jun 30, 2025 -41.34 Mn
Mar 31, 2025 -37.63 Mn
Dec 31, 2024 -34.58 Mn
Sep 30, 2024 -32.98 Mn
Jun 30, 2024 -29.20 Mn
Mar 31, 2024 -27.16 Mn
Dec 31, 2023 -25.43 Mn
Sep 30, 2023 -23.79 Mn
Jun 30, 2023 -12.05 Mn
Mar 31, 2023 -9.87 Mn
Dec 31, 2022 -18.84 Mn
Sep 30, 2022 -8.14 Mn
Dec 31, 2021 -13.84 Mn